New Zealand's PHARMAC to fund alternative treatments for asthma, scabies from Merck
12:29 EDT 31 Jul 2012 | thePharmaLetter
New Zealand's Pharmaceutical Management Agency PHARMAC is to fund a treatment for pre-schoolers with recurrent wheezing despite using other therapies, and for people with exercise-induced asthma.
Original Article: New Zealand's PHARMAC to fund alternative treatments for asthma, scabies from Merck
More From BioPortfolio on "New Zealand's PHARMAC to fund alternative treatments for asthma, scabies from Merck"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
